Illumina Q4 2024: A Fusion of Genomic Innovation and Strategic Growth
Illumina’s Q4 2024 performance reveals a story of resilience, strategic evolution, and innovative advancements in genomic research. With a revenue of $1.1 billion, the company is poised for growth despite facing challenges.
